Lobular carcinoma in situ with microinvasion

被引：0
|
作者：
Nemoto, T
Castillo, N
Tsukada, Y
Koul, A
Eckhert, KH
Bauer, RL
机构：
[1] Sisters Char Hosp, Dept Surg, Buffalo, NY USA
[2] Sisters Char Hosp, Dept Pathol, Buffalo, NY USA
[3] Breast Hlth Associates, Williamsville, NY USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 1998年 / 67卷 / 01期
关键词：
lobular carcinoma in situ; microinvasion; marker revision;
D O I：
10.1002/(SICI)1096-9098(199801)67:1<41::AID-JSO9>3.0.CO;2-M
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Six patients with lobular carcinoma in situ with microinvasion were described in this report. Lobular carcinoma in situ is not known to progress to microinvasive disease. Although this feature is rare, the current understanding that lobular carcinoma in situ is a marker needs to be revised. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码：41 / 46
页数：6
相关论文
共 50 条
  • [21] Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast
    Wood, WC
    SEMINARS IN ONCOLOGY, 1996, 23 (04) : 446 - 452
  • [22] Synchronous lobular carcinoma in situ and invasive lobular cancer: Marker or precursor for invasive lobular carcinoma
    Wallace, A. S.
    Xiang, D.
    Hockman, L.
    Arya, M.
    Jeffress, J.
    Wang, Z.
    Dale, P. S.
    EJSO, 2014, 40 (10): : 1245 - 1249
  • [23] Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
    Okumura, Yasuhiro
    Yamamoto, Yutaka
    Zhang, Zhenhuan
    Toyama, Tatsuya
    Kawasoe, Teru
    Ibusuki, Mutsuko
    Honda, Yumi
    Iyama, Ken-ichi
    Yamashita, Hiroko
    Iwase, Hirotaka
    BMC CANCER, 2008, 8 (1)
  • [24] Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ
    Obeng-Gyasi, Samilia
    Ong, Cecilia
    Hwang, E. Shelley
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
  • [25] Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
    Yasuhiro Okumura
    Yutaka Yamamoto
    Zhenhuan Zhang
    Tatsuya Toyama
    Teru Kawasoe
    Mutsuko Ibusuki
    Yumi Honda
    Ken-ichi Iyama
    Hiroko Yamashita
    Hirotaka Iwase
    BMC Cancer, 8
  • [26] Pleomorphic Lobular Carcinoma In Situ: Molecular Signature in Comparison to High-Grade Ductal Carcinoma In Situ and Classical Lobular Carcinoma In Situ
    Bakkar, Rania
    Vail, Eric
    Lopategui, Jean
    Engman, David
    Dadmanesh, Farnaz
    MODERN PATHOLOGY, 2018, 31 : 46 - 47
  • [27] Pleomorphic Lobular Carcinoma In Situ: Molecular Signature in Comparison to High-Grade Ductal Carcinoma In Situ and Classical Lobular Carcinoma In Situ
    Bakkar, Rania
    Vail, Eric
    Lopategui, Jean
    Engman, David
    Dadmanesh, Farnaz
    LABORATORY INVESTIGATION, 2018, 98 : 46 - 47
  • [28] The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma?
    Sanjay P. Bagaria
    Jaime Shamonki
    Michelle Kinnaird
    Partha S. Ray
    Armando E. Giuliano
    Annals of Surgical Oncology, 2011, 18 : 1845 - 1851
  • [29] Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma
    Mouabbi, Jason A.
    Raghavendra, Akshara Singareeka
    Bassett Jr, Roland L.
    Christgen, Matthias
    Middleton, Lavinia
    Teshome, Mediget
    Nasrazadani, Azadeh
    Hortobagyi, Gabriel
    Hassan, Amy
    Tripathy, Debasish
    Layman, Rachel M.
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [30] The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma?
    Bagaria, Sanjay P.
    Shamonki, Jaime
    Kinnaird, Michelle
    Ray, Partha S.
    Giuliano, Armando E.
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (07) : 1845 - 1851
12345